Clayton Associates
46
2M
28
1.77
1
0.39
14
- Stages of investment
- Areas of investment
Summary
Clayton Associates is the famous VC, which was founded in 1996. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Nashville.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. This Clayton Associates works on 2 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2017. The top activity for fund was in 2016.
We can highlight the next thriving fund investment areas, such as Software, Medical. Among the most popular portfolio startups of the fund, we may highlight Intechra Holdings, NuScriptRx, KeraFAST. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups.
This organization was formed by R. Clayton McWhorter, Stuart C. McWhorter.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Clayton Associates, startups are often financed by Nashville Capital Network, Claritas Capital, Innova Memphis. The meaningful sponsors for the fund in investment in the same round are Nashville Capital Network, Chrysalis Ventures, FCA Venture Partners. In the next rounds fund is usually obtained by Nashville Capital Network, VantagePoint Capital Partners, Richland Ventures.
Investments analytics
Analytics
- Total investments
- 46
- Lead investments
- 1
- Exits
- 14
- Rounds per year
- 1.77
- Follow on index
- 0.39
- Investments by industry
- Health Care (23)
- Software (16)
- Medical (14)
- Biotechnology (13)
- Information Technology (10) Show 44 more
- Investments by region
-
- United States (45)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.87
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hooke Bio | 19 Dec 2017 | Biotechnology | Seed | 1M | County Limerick, The Metropolitan District of Limerick City, Ireland |
| KeraFAST | 11 Apr 2012 | Biotechnology, E-Commerce, Medical, Life Science | Early Stage Venture | 3M | United States, Massachusetts, Boston |
| Pathfinder Therapeutics | 31 Oct 2008 | Biotechnology | Early Stage Venture | 5M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.